Onpattro
NDC 71336-1000, patisiran, injection, lipid complex, from Alnylam Pharmaceuticals, Inc..
- Product NDC
- 71336-1000
- Status
- Listed
- Labeler
- Alnylam Pharmaceuticals, Inc.
- Dosage form
- INJECTION, LIPID COMPLEX
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA210922
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71336-1000 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PATISIRAN SODIUM2 mg/mL
Pharmacologic classes
Decreased RNA Integrity [PE]; Increased Protein Breakdown [PE]; RNA, Small Interfering [CS]; Small Interfering RNA [EPC]; Transthyretin-directed RNA Interaction [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71336-1000-1 | 71336100001 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71336-1000-1) / 5 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/e87ec36f-b4b4-49d4-aea4-d4ffb09b0970Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=71336-1000
Use it
Look up 71336-1000 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71336-1000 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71336-1000. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.